110 related articles for article (PubMed ID: 37119607)
21. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
[TBL] [Abstract][Full Text] [Related]
22. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro.
Zhu Y; Pan Y; Zhang G; Wu Y; Zhong W; Chu C; Qian Y; Zhu G
Biol Pharm Bull; 2018 Jan; 41(1):36-46. PubMed ID: 29093327
[TBL] [Abstract][Full Text] [Related]
23. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study.
Ma D; Wang J; Liu L; Chen M; Wang Z
BMC Cancer; 2020 Sep; 20(1):936. PubMed ID: 32993568
[TBL] [Abstract][Full Text] [Related]
24. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):185-187. PubMed ID: 29552781
[TBL] [Abstract][Full Text] [Related]
25. MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells.
Honma N; Genda T; Matsuda Y; Yamagiwa S; Takamura M; Ichida T; Aoyagi Y
Lab Invest; 2006 Jul; 86(7):687-96. PubMed ID: 16636681
[TBL] [Abstract][Full Text] [Related]
26. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.
Zheng K; Li HY; Su XL; Wang XY; Tian T; Li F; Ren GS
J Exp Clin Cancer Res; 2010 Apr; 29(1):31. PubMed ID: 20380740
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
28. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
[TBL] [Abstract][Full Text] [Related]
29.
Yu Y; You S; Fan R; Shan X
Future Oncol; 2022 Mar; 18(8):979-990. PubMed ID: 35137600
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma cell-derived extracellular vesicles encapsulated microRNA-584-5p facilitates angiogenesis through PCK1-mediated nuclear factor E2-related factor 2 signaling pathway.
Shao Z; Pan Q; Zhang Y
Int J Biochem Cell Biol; 2020 Aug; 125():105789. PubMed ID: 32522621
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
Yau WL; Lam CS; Ng L; Chow AK; Chan ST; Chan JY; Wo JY; Ng KT; Man K; Poon RT; Pang RW
PLoS One; 2013; 8(3):e57882. PubMed ID: 23483935
[TBL] [Abstract][Full Text] [Related]
32. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
33. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
34. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
[TBL] [Abstract][Full Text] [Related]
35. Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion.
Jin C; Ye QH; Yuan FL; Gu YL; Li JP; Shi YH; Shen XM; Bo-Liu ; Lin ZH
Tumour Biol; 2015 Jun; 36(6):4309-17. PubMed ID: 25613068
[TBL] [Abstract][Full Text] [Related]
36. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
[TBL] [Abstract][Full Text] [Related]
38. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
39. Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma.
Yang XY; Zhang D; Zou QF; Fan F; Shen F
Med Oncol; 2013; 30(3):593. PubMed ID: 23794251
[TBL] [Abstract][Full Text] [Related]
40. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.
Zhou X; Zimonjic DB; Park SW; Yang XY; Durkin ME; Popescu NC
Int J Oncol; 2008 Jun; 32(6):1285-91. PubMed ID: 18497990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]